Photo taken from Daniel Shapiro/X
Jul 27, 2024, 11:35
Daniel Shapiro: Pleased to present our thoughts on the current adjuvant trials for RCC
Daniel Shapiro, Urologic Oncologist at UW Urology, shared a post on X about his recent paper commenting:
“Pleased to present our thoughts on the current adjuvant trials for Renal Cell Carcinoma (RCC). We evaluated trials using framework by Erik Van Zwet highlighting challenges and limits of current trial designs.”
Adjuvant therapy for renal cell carcinoma: Finding the signal in the noise published in ScienceDirect.
Authors: Daniel D. Shiparo, Pavlos Msaouel.
